Staar Surgical Return on Equity (ROE) Growth & History (STAA)
Staar Surgical's return on equity was −21.70% for fiscal 2025.
View full Staar Surgical company overviewStaar Surgical annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2026-01-02 | −21.70% | −16.54 pp |
| 2024 | 2024-12-27 | −5.16% | −11.07 pp |
| 2023 | 2023-12-29 | 5.91% | −7.36 pp |
| 2022 | 2022-12-30 | 13.27% | +1.28 pp |
| 2021 | 2021-12-31 | 11.99% | +8.68 pp |
| 2020 | 2021-01-01 | 3.31% | −6.30 pp |
| 2019 | 2020-01-03 | 9.61% | +3.95 pp |
| 2018 | 2018-12-28 | 5.67% | +10.96 pp |
| 2017 | 2017-12-29 | −5.29% | +26.31 pp |
| 2016 | 2016-12-30 | −31.61% | −14.40 pp |
| 2015 | 2016-01-01 | −17.20% | +4.89 pp |
| 2014 | 2015-01-02 | −22.10% | −23.23 pp |
| 2013 | 2014-01-03 | 1.13% | +6.89 pp |
| 2012 | 2012-12-28 | −5.76% | −10.96 pp |
| 2011 | 2011-12-30 | 5.20% | +4.95 pp |
| 2010 | 2010-12-31 | 0.24% | — |
Staar Surgical quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-07-03 | 2.25% | +7.14 pp |
| Q1 2026 | 2026-04-03 | 1.49% | +16.00 pp |
| Q4 2025 | 2026-01-02 | −5.25% | +3.05 pp |
| Q3 2025 | 2025-09-26 | 2.57% | +0.19 pp |
| Q2 2025 | 2025-06-27 | −4.90% | −6.74 pp |
| Q1 2025 | 2025-03-28 | −14.51% | −13.65 pp |
| Q4 2024 | 2024-12-27 | −8.29% | −10.32 pp |
| Q3 2024 | 2024-09-27 | 2.38% | +1.08 pp |
| Q2 2024 | 2024-06-28 | 1.84% | +0.11 pp |
| Q1 2024 | 2024-03-29 | −0.86% | −1.66 pp |
| Q4 2023 | 2023-12-29 | 2.03% | −0.02 pp |
| Q3 2023 | 2023-09-29 | 1.31% | −1.97 pp |
| Q2 2023 | 2023-06-30 | 1.73% | −2.78 pp |
| Q1 2023 | 2023-03-31 | 0.80% | −2.77 pp |
| Q4 2022 | 2022-12-30 | 2.05% | +0.12 pp |
| Q3 2022 | 2022-09-30 | 3.28% | +0.79 pp |
| Q2 2022 | 2022-07-01 | 4.51% | +0.69 pp |
| Q1 2022 | 2022-04-01 | 3.57% | +1.14 pp |
| Q4 2021 | 2021-12-31 | 1.93% | +0.14 pp |
| Q3 2021 | 2021-10-01 | 2.49% | — |
| Q2 2021 | 2021-07-02 | 3.82% | +4.51 pp |
| Q1 2021 | 2021-04-02 | 2.43% | +2.51 pp |
| Q4 2020 | 2021-01-01 | 1.79% | −2.34 pp |
| Q2 2020 | 2020-07-03 | −0.69% | −3.47 pp |
| Q1 2020 | 2020-04-03 | −0.08% | −1.10 pp |
| Q4 2019 | 2020-01-03 | 4.13% | +3.29 pp |
| Q3 2019 | 2019-09-27 | 1.63% | +0.00 pp |
| Q2 2019 | 2019-06-28 | 2.78% | −0.99 pp |
| Q1 2019 | 2019-03-29 | 1.01% | −0.30 pp |
| Q4 2018 | 2018-12-28 | 0.84% | +1.17 pp |
| Q3 2018 | 2018-09-28 | 1.62% | −1.35 pp |
| Q2 2018 | 2018-06-29 | 3.77% | +6.35 pp |
| Q1 2018 | 2018-03-30 | 1.31% | +7.20 pp |
| Q4 2017 | 2017-12-29 | −0.33% | +0.11 pp |
| Q3 2017 | 2017-09-29 | 2.97% | +7.67 pp |
| Q2 2017 | 2017-06-30 | −2.58% | +3.04 pp |
| Q1 2017 | 2017-03-31 | −5.89% | +14.95 pp |
| Q4 2016 | 2016-12-30 | −0.44% | +1.71 pp |
| Q3 2016 | 2016-09-30 | −4.70% | −0.28 pp |
| Q2 2016 | 2016-07-01 | −5.62% | −1.42 pp |
| Q1 2016 | 2016-04-01 | −20.84% | −14.47 pp |
| Q4 2015 | 2016-01-01 | −2.15% | +4.38 pp |
| Q3 2015 | 2015-10-02 | −4.42% | +2.15 pp |
| Q2 2015 | 2015-07-03 | −4.20% | +0.11 pp |
| Q1 2015 | 2015-04-03 | −6.37% | −2.98 pp |
| Q4 2014 | 2015-01-02 | −6.53% | — |
| Q3 2014 · Oct 3 | 2014-10-03 | −6.56% | −8.01 pp |
| Q2 2014 · Jul 4 | 2014-07-04 | −4.31% | −5.13 pp |
| Q1 2014 · Apr 4 | 2014-04-04 | −3.39% | −4.86 pp |
| Q3 2013 · Sep 27 | 2013-09-27 | 1.45% | +1.73 pp |
| Q2 2013 | 2013-06-28 | 0.83% | +2.40 pp |
| Q1 2013 | 2013-03-29 | 1.46% | +0.69 pp |
| Q4 2012 | 2012-12-28 | −4.39% | −4.77 pp |
| Q3 2012 | 2012-09-28 | −0.28% | −0.57 pp |
| Q2 2012 | 2012-06-29 | −1.58% | −5.17 pp |
| Q1 2012 | 2012-03-30 | 0.77% | — |
| Q4 2011 | 2011-12-30 | 0.38% | — |
| Q3 2011 | 2011-09-30 | 0.29% | — |
| Q2 2011 | 2011-07-01 | 3.59% | — |
Staar Surgical return on equity trends
Over the last five fiscal years, Staar Surgical's return on equity decreased from 3.31% to −21.70%, a change of −25.01 percentage points. The latest reported quarter, Q2 2026, shows 2.25%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Staar Surgical source filings ↗